NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 159 filers reported holding NOVAVAX INC in Q2 2015. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,827,000 | -59.7% | 1,449,700 | -33.5% | 0.12% | -57.0% |
| Q3 2016 | $4,534,000 | -71.4% | 2,179,700 | 0.0% | 0.28% | -71.4% |
| Q2 2016 | $15,846,000 | +40.9% | 2,179,700 | 0.0% | 0.97% | +54.5% |
| Q1 2016 | $11,247,000 | -38.5% | 2,179,700 | 0.0% | 0.63% | -31.3% |
| Q4 2015 | $18,288,000 | +23.3% | 2,179,700 | +3.9% | 0.91% | +6.0% |
| Q3 2015 | $14,829,000 | -30.3% | 2,097,500 | +9.9% | 0.86% | -25.1% |
| Q2 2015 | $21,263,000 | +34.7% | 1,908,700 | 0.0% | 1.15% | -3.1% |
| Q1 2015 | $15,785,000 | +39.5% | 1,908,700 | 0.0% | 1.19% | -3.8% |
| Q4 2014 | $11,319,000 | +42.2% | 1,908,700 | 0.0% | 1.24% | +11.2% |
| Q3 2014 | $7,959,000 | -9.7% | 1,908,700 | 0.0% | 1.11% | -7.3% |
| Q2 2014 | $8,818,000 | +11.8% | 1,908,700 | +9.6% | 1.20% | -2.0% |
| Q1 2014 | $7,886,000 | +19.6% | 1,740,900 | +35.2% | 1.22% | -39.7% |
| Q4 2013 | $6,591,000 | – | 1,287,300 | – | 2.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caption Management, LLC | 2,021,600 | $22,273,000 | 1.23% |
| GREAT POINT PARTNERS LLC | 4,500,000 | $2,479,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 860,000 | $474,000 | 0.23% |
| Sargent Investment Group, LLC | 588,070 | $324,000 | 0.16% |
| BB BIOTECH AG | 8,330,000 | $4,589,000 | 0.12% |
| GREAT POINT PARTNERS LLC | 2,000,000 | $1,102,000 | 0.11% |
| CENTAURUS FINANCIAL, INC. | 7 | $12,000,000 | 0.07% |
| Rock Springs Capital Management LP | 3,250,000 | $1,790,000 | 0.07% |
| Beirne Wealth Consulting Services, LLC | 155,000 | $85,000 | 0.07% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $138,000 | 0.07% |